Skip to content

Examination of the necessity of anti-TNF maintenance therapy for ulcerative colitis

Examination of the necessity of anti-TNF maintenance therapy for ulcerative colitis - EXAMU study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000015008
Enrollment
50
Registered
2014-08-31
Start date
2014-08-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Sponsors

Center for GI/IBD
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Ulcerative colitis patients with clinical remission and mucosalhealing for anti-TNF maintenance therapy and without steroid

Exclusion criteria

Exclusion criteria: Ulcerative colitis patients without clinical remission. Patients under pregnancy and breast-feeding or the female patient that may have become pregnant. Patients judged to be disqualified .

Design outcomes

Primary

MeasureTime frame
Remission rate after the discontinuation of anti-TNF maintenance therapy

Secondary

MeasureTime frame
The feature of ulcerative colitis patients with clinical remission after the discontinuation of anti-TNF maintenance therapy

Countries

Japan

Contacts

Public ContactAtsushi Yoshida

Ofuna Chuo Hospital Center for GI/IBD

atushi.y@kza.biglobe.ne.jp+81-46-745-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026